论文信息 - Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer. - 字舞流文

Phase II study of intraperitoneal cisplatin plus systemic etoposide as second-line treatment in patients with small volume residual ovarian cancer.

A. V. D. Van Der Zee | N. Mulder | E. de Vries | W. T. van der Graaf | D. Sleijfer | P. Willemse | H. Boonstra | R. S. de Jong | W. V. D. van der Graaf